In a ray of hope for people suffering from depression researchers have identified a compound that may treat depression just as effectively as the psychoactive drug ketamine without the unwanted side effects associated with it. The compound hydroxynorketamine (HNK) produces the same beneficial effects attributed to ketamine without its unwanted side effects a new research showed. 'The clinical use of ketamine therapy for depression is limited because the drug is administered intravenously and may produce adverse effects such as hallucinations and sedation to the point of anaesthesia' said Irving Wainer a senior investigator from the National Institute on Aging in